Chargement en cours...
Emodin inhibits colon cancer by altering BCL-2 family proteins and cell survival pathways
BACKGROUND: Currently offered therapeutics to treat colon cancer (CoCa) are toxic when given at maximum tolerated dose to achieve optimal clinical response. Hence, less toxic therapeutic intervention is needed to treat CoCa. In this study, we investigated the effect of a natural agent, Emodin, on Co...
Enregistré dans:
| Publié dans: | Cancer Cell Int |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BioMed Central
2019
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6466701/ https://ncbi.nlm.nih.gov/pubmed/31011292 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-019-0820-3 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|